Comparison of tailored < em > Helicobacter pylori < /em > eradication versus modified bismuth quadruple therapy in Korea: a randomized controlled trial

CONCLUSION: PAM-B therapy exhibits similar efficacy and improved cost-effectiveness compared to TT based on the results of DPO-PCR tests.Clinical trial registration: www.clinicaltrials.gov identifier is NCT05002595.PMID:34883037 | DOI:10.1080/14787210.2022.2017280

Source: Expert Review of Anti-Infective Therapy - December 9, 2021 Category: Infectious Diseases Authors: Jun-Hyung Cho So-Young Jin Suyeon Park Source Type: research